Connect with us

Mental health

ADHD patients say cannabis helps ease symptoms

According to a survey, cannabis helps mitigate symptoms and allows patients to reduce prescription medications

Published

on

ADHD AND CANNABIS
ADHD is one of the most commonly diagnosed neurodiverse conditions in the UK.

Patients with ADHD report that cannabis helps mitigate some of their symptoms, according to a new study.

Survey data published earlier this month reveals that ADHD patients are self-medicating with cannabis to ease symptoms and reduce side-effects of their prescription medications.

Attention Deficit Hyperactivity Disorder (ADHD) is a neurological disorder, which can affect people’s behaviour in that they can seem restless, have difficulty concentrating and seem impulsive. 

It is one of the most commonly diagnosed neurodiverse conditions in the UK. 

Read more about ADHD here 

Mental health

Researchers at Washington State University conducted an online survey involving 1,738 students with ADHD. 

Participants who had used cannabis reported that it has “beneficial effects” on many symptoms of ADHD, including hyperactivity and impulsivity. 

Cannabis was also said to improve most of their medication side effects, such as irritability and anxiety. 

According to the NHS, there are five drugs available for ADHD that are stimulant based, but these come with side effects that include jitteriness, irritability, moodiness, headaches, stomachaches, fast heart rate, and high blood pressure.

Researchers reported that regular cannabis use was able to moderate associations between “symptom severity and executive dysfunction”

Authors concluded, “[P]eople with ADHD may be using cannabis to self-medicate for many of their symptoms and medication side effects and that more frequent use may mitigate ADHD-related executive dysfunction.”

Prior studies

An earlier UK study found that cannabis extracts were associated with improvements in cognition and behavior in people with ADHD.

Israeli data published last year further reported that ADHD patients with legal access to medical cannabis products were able to reduce their use of prescription medications. 

[activecampaign form=33]

Sarah Sinclair is an award-winning freelance journalist covering health, drug policy and social affairs. She is one of the few UK reporters specialising in medical cannabis policy and as the former editor of Cannabis Health has covered developments in the European cannabis sector extensively, with a focus on patients and consumers. She continues to report on cannabis-related health and policy for Forbes, Cannabis Health and Business of Cannabis and has written for The i Paper, Byline Times, The Lead, Positive News, Leafie & others. Sarah has an NCTJ accreditation and an MA in Journalism from the University of Sunderland and has completed additional specialist training through the Medical Cannabis Clinicians Society in the UK. She has spoken at leading industry events such as Cannabis Europa.

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.